Delcath Systems, Inc. (DCTH) P/E Ratio History
UndervaluedTrading at 191.6x vs 5Y avg 540.3x · 50th percentile · Below historical baseline · Data 2018–2026
Loading P/E history...
P/E Ratio Analysis
As of June 30, 2026, Delcath Systems, Inc. (DCTH) trades at a price-to-earnings ratio of 191.6x, with a stock price of $12.95 and trailing twelve-month earnings per share of $0.02.
The current P/E is 65% below its 5-year average of 540.3x. Over the past five years, DCTH's P/E has ranged from a low of 0.1x to a high of 1546.7x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.9x, DCTH trades at a 737% premium to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.6x.
Relative to the broader market, DCTH commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DCTH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DCTH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
DCTH P/E vs Peers
Imaging, radiation, and oncology devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $9B | 30.1 | 1.31 | -25% | |
| $2B | 7.0Lowest | 0.68Best | +817% | |
| $9B | 20.1 | - | +1747%Best | |
| $104B | 21.7 | 3.10 | +3% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
DCTH Historical P/E Data (2018–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $9.28 | $0.01 | 1546.7x | +186% |
| FY2025 Q4 | Dec 31 2025 | $10.10 | $0.06 | 160.8x | -70% |
| FY2025 Q3 | - | $10.75 | $0.01 | 1235.6x | +129% |
| FY2025 Q2 | Jun 30 2025 | $13.60 | $0.05 | 298.2x | -45% |
| FY2020 Q3 | Sep 30 2020 | $11.61 | $75.06 | 0.2x | -100% |
| FY2018 Q4 | Dec 31 2018 | $196.00 | $1628.22 | 0.1x | -100% |
Average P/E for displayed period: 540.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DCTH — Frequently Asked Questions
Quick answers to the most common questions about buying DCTH stock.
What is DCTH's P/E ratio?
Delcath Systems, Inc. (DCTH) trailing twelve-month P/E ratio is 191.6x, based on TTM diluted EPS of $0.02. The 5-year average P/E is 540.3x and the historical range spans 0.1x to 1546.7x.
Is DCTH stock overvalued or undervalued?
DCTH trades at 191.6x P/E, below its 5-year average of 540.3x. At the 50th percentile of its historical range (0.1x–1546.7x), the stock is priced at a discount to its own history.
Is DCTH stock expensive?
No, DCTH is not expensive on a historical basis. The current P/E of 191.6x is below the 5-year average of 540.3x and sits at the 50th percentile of its valuation range.
What is DCTH's historical P/E range?
Over the past 5 years, DCTH's P/E ratio has ranged from 0.1x to 1546.7x, with a median of 298.2x and an average of 540.3x. The current P/E of 191.6x places the stock at the 50th percentile of this range. Full historical data spans 2018–2026.
How does DCTH's P/E compare to the S&P 500?
DCTH trades at 191.6x P/E versus the S&P 500 median of 25.1x. The 663% premium to the market typically reflects higher expected earnings growth or quality.
How does DCTH's valuation compare to Healthcare peers?
Delcath Systems, Inc. P/E of 191.6x compares to the Healthcare sector median of 22.9x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is DCTH's PEG ratio?
DCTH PEG ratio is N/A, based on a P/E of 191.6x and EPS growth of 107.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is DCTH's earnings yield?
DCTH earnings yield is 0.52%, the inverse of its 191.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.